Please use this identifier to cite or link to this item:
Title: Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases
Authors: Simovic Markovic, Bojana
Kanjevac, Tatjana
Harrell C.
Gazdic, Marina
Fellabaum C.
Arsenijevic, Nebojsa
Volarevic, Vladislav
Journal: Stem Cell Reviews and Reports
Issue Date: 1-Apr-2018
Abstract: © 2017, Springer Science+Business Media, LLC, part of Springer Nature. Mesenchymal stem cells (MSCs) are promising resource for the therapy of inflammatory bowel diseases (IBDs) on the grounds of their differentiation capabilities and immuno-modulatory characteristics. Results of clinical studies indicate that local application of MSCs is a secure and beneficial approach for the treatment of perianal fistulas while systemic application of MSCs leads to the attenuation or aggravation of IBDs. Herein, we emphasized molecular mechanisms and approaches that should improve efficacy of MSC-based therapy of IBDs.
Type: review
DOI: 10.1007/s12015-017-9789-2
ISSN: 15508943
SCOPUS: 85034848180
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)




Files in This Item:
File Description SizeFormat 
  Restricted Access
29.86 kBAdobe PDFThumbnail

Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.